OKYO Pharma Limited (OKYO) Net income 2020–2025
OKYO Pharma Limited (OKYO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$4.7MFY2025 · since FY2020: -$1.5M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | +72.0% |
| FY2024 | -$16.8M | -26.8% |
| FY2023 | -$13.3M | -144.4% |
| FY2022 | -$5.4M | -62.0% |
| FY2021 | -$3.4M | -117.2% |
| FY2020 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OKYO financial trends
OKYO RevenueOKYO Net marginOKYO Gross profitOKYO Gross marginOKYO Operating incomeOKYO Operating marginOKYO Operating cash flowOKYO Free cash flowOKYO Capital expendituresOKYO Return on equityOKYO Stock buybacksOKYO Dividends paidOKYO Total assetsOKYO Total liabilitiesOKYO Shareholders’ equityOKYO overview →